1. Home
  2. RGS vs ATYR Comparison

RGS vs ATYR Comparison

Compare RGS & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Regis Corporation

RGS

Regis Corporation

N/A

Current Price

$25.84

Market Cap

66.3M

ML Signal

N/A

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.73

Market Cap

79.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGS
ATYR
Founded
1922
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
66.3M
79.2M
IPO Year
1991
2015

Fundamental Metrics

Financial Performance
Metric
RGS
ATYR
Price
$25.84
$0.73
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$8.75
AVG Volume (30 Days)
5.7K
2.0M
Earning Date
02-11-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
20.05
N/A
EPS
45.08
N/A
Revenue
$223,032,000.00
$190,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$18,728.88
P/E Ratio
$0.58
N/A
Revenue Growth
13.98
N/A
52 Week Low
$15.00
$0.64
52 Week High
$31.50
$7.29

Technical Indicators

Market Signals
Indicator
RGS
ATYR
Relative Strength Index (RSI) 35.83 43.23
Support Level $24.98 $0.71
Resistance Level $27.75 $0.76
Average True Range (ATR) 0.77 0.05
MACD -0.31 0.01
Stochastic Oscillator 11.66 22.17

Price Performance

Historical Comparison
RGS
ATYR

About RGS Regis Corporation

Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Share on Social Networks: